BSE: 500488 | NSE: ABBOTINDIA | Pharmaceuticals & Drugs | Mid Cap
1. Is Abbott India Ltd a good quality company?
Past 10 year's financial track record analysis by Moneyworks4me indicates that Abbott India Ltd is a good quality company.
2. Is Abbott India Ltd undervalued or overvalued?
The key valuation ratios of Abbott India Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
3. Is Abbott India Ltd a good buy now?
The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Abbott India Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘ
Value Creation Index Colour Code Guide ⓘ
|ROCE % ⓘ||23.4%||27.3%||26.8%||24.3%||21.8%||24.4%||24.2%||27.3%||28.1%||30.1%||-|
|Value Creation Index ⓘ||0.7||1.0||1.0||0.8||0.6||0.8||0.8||1.4||1.5||1.7||-|
Growth Parameters ⓘ
Growth Parameters Colour Code Guide ⓘ
|YoY Gr. Rt. %||-||10.2%||25.7%||14.2%||11%||13.6%||11.5%||11.3%||5.3%||14.1%||-|
|Adj EPS ⓘ||65.5||73.8||108.7||121.3||131.9||175.6||210.2||281.9||326.4||377.2||446.8|
|YoY Gr. Rt. %||-||12.8%||47.2%||11.7%||8.7%||33.2%||19.7%||34.1%||15.8%||15.6%||-|
|BVPS (₹) ⓘ||304.4||296.6||441.2||562.7||646.4||786.8||932.2||1,127.5||1,203.7||1,306.2||1,500.5|
|Adj Net Profit ⓘ||139||157||231||258||280||373||447||599||694||802||949|
|Cash Flow from Ops. ⓘ||101||124||215||249||307||153||499||626||727||948||-|
|Debt/CF from Ops. ⓘ||0||0||0||0||0||0||0||0||0||0||-|
CAGR Colour Code Guide ⓘ
|9 Years||5 Years||3 Years||1 Years|
|Adj EPS ⓘ||21.5%||23.4%||21.5%||15.6%|
Key Financial Parameters ⓘ
Performance Ratio Colour Code Guide ⓘ
|Return on Equity % ⓘ||23.4||27.3||26.8||24.2||21.7||24.2||24.1||27||27.6||29.6||31.8|
|Op. Profit Mgn % ⓘ||12.3||12.1||13.8||14.1||13.8||16||16.5||18.7||21.4||22.2||22.6|
|Net Profit Mgn % ⓘ||8.4||8.6||10.1||9.9||9.7||11.3||12.1||14.6||16.1||16.3||17.8|
|Debt to Equity ⓘ||0||0||0||0||0||0||0||0||0||0||0|
|Working Cap Days ⓘ||192||163||219||146||93||116||119||98||91||85||203|
|Cash Conv. Cycle ⓘ||55||46||44||32||19||17||9||-2||-5||-13||122|
Return on Equity has increased versus last 3 years average to 31.80%
Sales growth is growing at healthy rate in last 3 years 10.17%
Sales growth is not so good in last 4 quarters at 8.84%
|TTM EPS (₹)||446.8||0|
|TTM Sales (₹ Cr.)||5,349||0|
|BVPS (₹.) ⓘ||1,500.5||0|
|Reserves (₹ Cr.) ⓘ||3,167||116|
|From the Market|
|52 Week Low / High (₹)||17349.05 / 23142.55|
|All Time Low / High (₹)||145.00 / 23902.30|
|Market Cap (₹ Cr.)||46,341|
|Equity (₹ Cr.)||21.3|
|Face Value (₹)||10|
|Industry PE ⓘ||38|
Since 1910, Abbott has been dedicated to helping people in India live healthier lives through a diverse range of science-based nutritional products, diagnostic tools, branded generic pharmaceuticals, and diabetes and vascular devices. Abbott India Limited is a public limited company domiciled and incorporated in India under the provisions of the then Companies Act, 1913. The company is listed and traded on the Bombay Stock Exchange. It is traded on the National Stock Exchange under the ‘permitted category’.
Abbott India, a publicly listed company and a subsidiary of Abbott Laboratories, takes pride in offering high-quality trusted medicines in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders and primary care.
One of India's fastest-growing pharmaceutical companies, Abbott India Limited is part of Abbott's global pharmaceutical business in India. It has expertise across product development, manufacturing, sales and customer service and dedicated to providing high-quality, reliable products with the expert clinical support customers need.
Abbott India provides quality healthcare through a mix of global and local products for people in India. Its in-house development and medical teams undertake product and clinical development tailored to the unique needs of the Indian market. Its employees work to produce high-quality, high-volume formulations using cost efficient processes. And, its trained personnel are dedicated to ensuring compliance with international quality standards.
Business area of the company
The company is one of the leading multinational pharmaceutical companies in India and operates with owned manufacturing units and various independent contract/third party manufacturers based across the country. The company sells its products through independent distributors primarily within India.
Products and Services offered by the company
History and Milestones
Dr. Abbott’s spirit of entrepreneurship, innovation and caring lives on in culture, business and contributions to medical science. Read below for historical moments that highlights the pursuit of the extraordinary throughout the years.